Univest
Univest
  • Markets

Indraprastha Medical Corporation (INDRAMEDCO) Share Price Rise: Stock Gains 8.20% Today

  • November 16, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Indraprastha Medical Corporation Share Price
Indraprastha Medical Corporation Ltd. (INDRAMEDCO) share price rose to Rs 357.4 today, up 8.2% from the previous close. Market cap was Rs 3,027.96 crore.

Indraprastha Medical Corporation Share Price stood at Rs 357.40 at 11:52 AM IST on 16 November 2026, up Rs 27.10 or 8.20% from the previous close of Rs 330.30. The company has a market capitalisation of Rs 3,027.96 crore, according to latest Univest data.

Univest data confirms the move itself, though no company-specific trigger has been identified. What the numbers do show is a stock that opened at Rs 328.85, touched a low of Rs 325.90 and a high of Rs 357.40, and was trading right at that high at the time of writing. That makes the Indraprastha Medical Corporation share price rise one of the clearer Stocks Rising Today entries to examine on Univest.

Table of Contents

Toggle
  • Indraprastha Medical Corporation Share Price Today: Price Action Analysis
  • Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Indraprastha Medical Corporation
  • About Indraprastha Medical Corporation
  • Frequently Asked Questions
    • What is the Indraprastha Medical Corporation Share Price today?
    • Why is the Indraprastha Medical Corporation stock rising today?
    • What is the market capitalisation behind the Indraprastha Medical Corporation Share Price?
    • What is the P/E Ratio of Indraprastha Medical Corporation?
    • What are the ROE and ROCE of Indraprastha Medical Corporation?
    • What are the EPS, book value and dividend yield behind the Indraprastha Medical Corporation Share Price?
    • How does the Indraprastha Medical Corporation Share Price compare with peer valuations?
    • What is the day range of the Indraprastha Medical Corporation Share Price Today?
  • Track Indraprastha Medical Corporation Share Price on Univest

Indraprastha Medical Corporation Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 357.4
Previous Close Rs 330.3
Today's Move Rs 27.1 (+8.2%)
Open Rs 328.85
High Rs 357.4
Low Rs 325.9
Market Capitalisation Rs 3,027.96 crore
Market Cap Category Small Cap

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) rose to Rs 357.4 from the previous close of Rs 330.3, a move of Rs 27.1 or 8.2%. The stock opened at Rs 328.85, reached a high of Rs 357.4, recorded a low of Rs 325.9.

Indraprastha Medical Corporation Share Price Today is Rs 357.40, a gain of Rs 27.10 or 8.20% over the previous close of Rs 330.30. The stock opened at Rs 328.85, touched a low of Rs 325.90 and a high of Rs 357.40, and last traded at Rs 357.40. Market capitalisation stands at Rs 3,027.96 crore.

The opening price of Rs 328.85 was Rs 1.45 under the previous close, and the day low of Rs 325.90 was Rs 2.95 under the open. From the open, the price has moved Rs 28.55 higher to reach its current level.

The gap between the day low and the day high is Rs 31.50, and the last traded price of Rs 357.40 is the same as the day high. These Indraprastha Medical Corporation Stock Performance figures are as of 11:52 AM IST and will change as trading continues, so the Indraprastha Medical Corporation Share Price Update below should be read as a snapshot of the late morning.

Price action is only one part of the picture, so the next section looks at the fundamentals behind the stock.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) Fundamental Analysis

Metric Value
Market Capitalisation Rs 3,027.96 crore
P/E Ratio 15.76x
P/B Ratio 3.72x
ROE 27.47%
ROCE 37.7%
EPS Rs 20.96
Book Value Per Share Rs 88.84
Dividend Yield 1.21%

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) fundamental metrics show P/E 15.76x, P/B 3.72x, ROE 27.47%, ROCE 37.7%. Read together, these ratios describe the company’s position rather than a recommendation.

Indraprastha Medical Corporation Ltd. has a market capitalisation of Rs 3,027.96 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 15.76x, P/B at 3.72x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.47% and ROCE of 37.7%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.96, book value per share of Rs 88.84, dividend yield of 1.21%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 44.34x, median ROE of 12.88%, median ROCE of 15.43%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Hospital & Healthcare Services
Benchmark Scope same industry
Company P/E Ratio 15.76x
Benchmark Median P/E 44.34x
Benchmark Average P/E 74.75x
Benchmark P/E Range 6.09x to 755.5x
Company P/B Ratio 3.72x
Benchmark Median P/B 3.62x
Company ROE 27.47%
Benchmark Median ROE 12.88%
Company ROCE 37.7%
Benchmark Median ROCE 15.43%
Company Market Capitalisation Rs 3,027.96 crore
Benchmark Median Market Cap Rs 583.5 crore

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 15.76x, which is below the benchmark median of 44.34x, a difference of -64.46%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROE of 27.47%, which is above the benchmark median of 12.88%, a difference of +113.28%. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a ROCE of 37.7%, which is above the benchmark median of 15.43%, a difference of +144.33%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Apollo Hospitals Enterprise Ltd. APOLLOHOSP 1,22,439.82 54.61 11.55 23.54 21.73
Max Healthcare Institute Ltd. MAXHEALTH 91,979.41 66.62 8.12 14.53 14.97
MANIPAL HEALTH ENTERPRI L MANIPALHOS 89,445.65 100.24 5.35 12.95 13.93
Aster DM Healthcare Ltd. ASTERDM 62,952.18 133.74 8.46 13.07 16.22
Fortis Healthcare Ltd. FORTIS 57,754.3 55.62 5.51 11.32 14.07

Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a P/E ratio of 15.76x compared with the displayed peer median of 66.62x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 27.47% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 37.7% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Indraprastha Medical Corporation Ltd. (INDRAMEDCO) has a market capitalisation of Rs 3,027.96 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Indraprastha Medical Corporation

Indraprastha Medical Corporation is one of the stocks rising today, and these five verified points frame the move without any recommendation.

  • Price action: Rs 357.40 against a previous close of Rs 330.30, a gain of 8.20%.
  • Day range: an open at Rs 328.85, a day low of Rs 325.90 and a day high of Rs 357.40 that matches the last price.
  • Valuation: a P/E of 15.76, below the industry median of 44.34, and a P/B of 3.72 against a median of 3.62.
  • Returns: ROE of 27.47% and ROCE of 37.70%, above the medians of 12.88% and 15.43%.
  • Size: a market capitalisation of Rs 3,027.96 crore against an industry median of Rs 583.50 crore.

About Indraprastha Medical Corporation

Indraprastha Medical Corporation Ltd. trades under the symbol INDRAMEDCO and operates in the Healthcare sector, within the Hospital & Healthcare Services industry. With a market capitalisation of Rs 3,027.96 crore, it belongs to a same-industry group of 67 companies that includes Apollo Hospitals Enterprise, Max Healthcare Institute and Fortis Healthcare. Further Company Overview details are available on the Univest stock page, while this article sticks to verified price and ratio figures.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Indraprastha Medical Corporation Share Price today?

Ans. Indraprastha Medical Corporation Share Price was Rs 357.40 at 11:52 AM IST on 16 November 2026, up Rs 27.10 or 8.20% from the previous close of Rs 330.30. The stock opened at Rs 328.85 and has touched a high of Rs 357.40.

Why is the Indraprastha Medical Corporation stock rising today?

Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. The Indraprastha Medical Corporation Share Price rose 8.20% to Rs 357.40, and the day range so far runs from Rs 325.90 to Rs 357.40.

What is the market capitalisation behind the Indraprastha Medical Corporation Share Price?

Ans. Indraprastha Medical Corporation has a market capitalisation of Rs 3,027.96 crore, according to latest Univest data. Market capitalisation describes company size rather than quality, and it sits above the same-industry median of Rs 583.50 crore across 67 companies.

What is the P/E Ratio of Indraprastha Medical Corporation?

Ans. The P/E Ratio of Indraprastha Medical Corporation is 15.76, compared with a same-industry median of 44.34 and an average of 74.75. The P/B Ratio is 3.72 against a benchmark median of 3.62, according to the latest Univest figures.

What are the ROE and ROCE of Indraprastha Medical Corporation?

Ans. Indraprastha Medical Corporation reports ROE of 27.47% and ROCE of 37.70%. The same-industry benchmark medians are 12.88% for ROE and 15.43% for ROCE, so both return ratios sit above those reference points, according to latest Univest data.

What are the EPS, book value and dividend yield behind the Indraprastha Medical Corporation Share Price?

Ans. EPS is Rs 20.96, book value per share is Rs 88.84 and dividend yield is 1.21%. Dividend yield is historical data, not a guide to future payouts, and EPS shows the earnings attributable to each share.

How does the Indraprastha Medical Corporation Share Price compare with peer valuations?

Ans. Against Apollo Hospitals Enterprise, Max Healthcare Institute, Manipal Health Enterprises, Aster DM Healthcare and Fortis Healthcare, Indraprastha Medical Corporation has a P/E Ratio of 15.76 below the peer range of 54.61 to 133.74, and a smaller market capitalisation of Rs 3,027.96 crore.

What is the day range of the Indraprastha Medical Corporation Share Price Today?

Ans. The stock opened at Rs 328.85, touched a low of Rs 325.90 and a high of Rs 357.40. At 11:52 AM IST it last traded at Rs 357.40, which is the same as the day high.

Track Indraprastha Medical Corporation Share Price on Univest

Use Indraprastha Medical Corporation Ltd. (INDRAMEDCO) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track the Indraprastha Medical Corporation Share Price live on Univest, along with fundamental ratios, 52-week levels and market insights. Univest brings the P/E Ratio, P/B Ratio, ROE and ROCE together on one page, so the Indraprastha Medical Corporation Share Price Today can be read against its sector and peers whenever the figures change. Univest also publishes Market Update pages for stocks in the news, with no recommendation attached.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply